^Longley DB, Harkin DP, Johnston PG (2003 May). „5-fluorouracil: mechanisms of action and clinical strategies”. Nat Rev Cancer. 3 (5): 330—8. PMID12724731.Проверите вредност парамет(а)ра за датум: |date= (помоћ)CS1 одржавање: Вишеструка имена: списак аутора (веза)
^Petty RD, Cassidy J (2004 Mar). „Novel fluoropyrimidines: improving the efficacy and tolerability of cytotoxic therapy”. Curr Cancer Drug Targets. 4 (2): 191—204. PMID15032669.Проверите вредност парамет(а)ра за датум: |date= (помоћ)
^Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
^Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID11749573. doi:10.1021/ci000392t.
^Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID11020286. doi:10.1021/jm000942e.
. PMID 21059682. doi:10.1093/nar/gkq1126.
